Replicor Inc. logo

Replicor Inc. jobs and careers

Canada

As of October 23, 2026, Replicor Inc. has no open roles listed.

About Replicor Inc.

Replicor Inc. is a Canadian biotechnology company focused on the development of its nucleic acid polymer (NAP) technology for the treatment of hepatitis B (HBV) and delta (HDV) infections. NAPs are the only antiviral agent to directly target the immunosuppressive protein (HBsAg) which drives chronic HBV infection and liver disease. Our lead clinical NAP drug product is REP 2139-Mg, a proprietary formulation of REP 2139 which makes once weekly subcutaneous injections easily tolerated. Replicor's latest clinical data demonstrates that NAP-based combination therapy can restore immune control of HBV infection in 78% of patients and eliminate HDV infection in 74% of patients. These effects persist in the absence of any therapy, allowing the liver to heal. REP 2139-Mg based combination promises to revolutionize the therapy of chronic HBV and HDV infection and play a pivotal role in the WHO's goal of eliminating viral hepatitis by 2030.

Employees
1 to 10
Headquarters
Canada

Leadership

The top of Replicor Inc.'s org chart, with how many people report into each leader.

JD

John Dilatush

Chief Executive Officer

Replicor Inc. jobs: common questions

Is Replicor Inc. hiring right now?
Replicor Inc. has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Replicor Inc.'s careers site.
Where is Replicor Inc. headquartered?
Replicor Inc. is headquartered in Canada.
Who leads Replicor Inc.?
John Dilatush, Chief Executive Officer, is at the top of Replicor Inc.'s org chart.
How do I apply for a job at Replicor Inc.?
Pick a role on Replicor Inc.'s TheJobsMap page and select Apply. Every listing links to the original posting on Replicor Inc.'s own careers site, so you apply directly with the employer.